# Sulfasalazine

## Salazine 500mg

##### 

| 藥品代碼   | OSAL5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Inflammatory bowel disease including Crohn's disease， ulcerative colitis， Active RA， ankylosing spondylitis.                                                                                                                                                                                                                                                                                                                                                                                                    |
| 用法用量   | Inflammatory bowel disease including Crohn's disease， ulcerative colitis: Adult moderate attacks: 2 tables TID-QID. Severe attacks: 2-4 TABTID-QID. Children: 40-60 mg/kg/day in 3-6 doses. Maintenance: Adult 2 tablets BID-TID. Children 20-30 mg/kg/day in 3-6 divided doses. RA : 2 tablets BID. Child (Juvenile chronic arthritis)， no enough information.                                                                                                                                                  |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 禁忌       | Hypersensitivity to sulfonamides & salicylates. Acute intermittent porphyria. Infant < 2 years.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 副作用     | Nausea， anorexia， raised temp; erythema & pruritus; headache. Rarely， hematological， GI， CNS， renal， dermatological reactions. Dermatologic: Pruritus (3% to 4% )， Rash (3% to 13% ) Gastrointestinal: Abdominal pain (8% )， Indigestion (13% to 33% )， Loss of appetite (33% )， Nausea (19% to 33% )， Stomatitis (4% )， Vomiting (8% to 33% ) Neurologic: Dizziness (4% )， Headache (9% to 33% ) Renal: Discolored urine Reproductive: Oligozoospermia， Reversible (33% ) Other: Fever (3% to 5% ) |
| 孕期建議   | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                               |

